Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenues
Operating Expenses:        
Research and development 2,095 1,139 3,745 3,226
Selling, general and administrative (including $398 and $463 from stock compensation granted to officers, directors and employees for the three months ended June 30, 2023 and 2022, respectively, and $905 and $910 for the six months ended June 30, 2023 and 2022, respectively) 1,526 1,875 3,541 5,230
Loss from Operations 3,621 3,014 7,286 8,456
Other (Income) Expense        
Interest income (220) (36) (384) (44)
Interest expense 1 213
Change in fair value of warrant liability (1,387) (5) (4,311) (23)
Gain on extinguishment of debt (14) (547)
Unrealized (gain) loss on marketable securities (9) 6 (38) 30
Total Other (Income), net (1,629) (35) (5,067) (37)
Net Loss $ (1,992) $ (2,979) $ (2,219) $ (8,419)
Net Loss Per Share - Basic $ (0.05) $ (0.10) $ (0.06) $ (0.26)
Net Loss Per Share - Diluted $ (0.05) $ (0.10) $ (0.06) $ (0.26)
Weighted average common shares outstanding - basic 40,172,599 31,237,560 39,632,060 31,865,425
Weighted average common shares outstanding - diluted 40,172,599 31,237,560 39,632,060 31,865,425